1. Home
  2. CINT vs CTKB Comparison

CINT vs CTKB Comparison

Compare CINT & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CI&T Inc

CINT

CI&T Inc

HOLD

Current Price

$5.07

Market Cap

704.9M

Sector

Technology

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.37

Market Cap

652.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CINT
CTKB
Founded
1995
1990
Country
Brazil
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
704.9M
652.1M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CINT
CTKB
Price
$5.07
$4.37
Analyst Decision
Strong Buy
Hold
Analyst Count
5
4
Target Price
$7.02
$5.63
AVG Volume (30 Days)
93.1K
707.3K
Earning Date
03-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$193,015,000.00
Revenue This Year
$15.86
$5.42
Revenue Next Year
$11.23
$7.03
P/E Ratio
$17.94
N/A
Revenue Growth
N/A
17.67
52 Week Low
$3.98
$2.37
52 Week High
$6.71
$6.18

Technical Indicators

Market Signals
Indicator
CINT
CTKB
Relative Strength Index (RSI) 49.75 47.63
Support Level $4.93 $4.00
Resistance Level $5.51 $4.51
Average True Range (ATR) 0.25 0.18
MACD -0.04 0.02
Stochastic Oscillator 35.04 53.12

Price Performance

Historical Comparison
CINT
CTKB

About CINT CI&T Inc

CI&T Inc is engaged in providing plans, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: